A novel drug reduces the monthly frequency of seizure in adults with focal epilepsy Post author: Post published: October 11, 2023 Post category:uncategorized The effect of a novel Kv7.2/Kv7.3 potassium channel opener XEN1101 in reducing monthly seizure frequency in adults. You Might Also Like Novel antibodies show promise for tumor targeting and RAD51 inhibition October 21, 2024 California looked to them to close health disparities, then it backpedaled July 28, 2025 NR2F1 promotes cataract formation by activating STAT3 pathway April 30, 2025